1) Allington HV, Allington JH. Eyelid tumors. Arch Dermatol 1968;97:50-65.
3) Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors. A retrospective study of 5,504 cases and review of literature. Am J Dermatopathol 2009;31:256-62.
4) Lee SH, Kim MS. The malignant tumors of the eye. J Korean Ophthalmol Soc 1977;18:327-33.
5) Bak SI, Lee SH, Bak BG. Benign tumors of the eye and its adnexa. J Korean Ophthalmol Soc 1978;19:333-9.
6) Roh KK, Lee JH, Youn DH. Clinical analysis in tumors of the eye and its adnexa. J Korean Ophthalmol Soc 1987;28:137-42.
7) Lee TW, Yang SW, Kim BH, Song JS. A clinicopathologic study of 46 cases of eyelid malignancy. J Korean Ophthalmol Soc 1995;36:2087-94.
8) Kim KH, Chung WS. Classification and therapeutic effect of benign and malignant eyelid tumors. J Korean Ophthalmol Soc 1997;38:703-9.
9) Lee TS, Lee JJ. Analysis of classification and incidence of eyelid and orbital tumors. J Korean Ophthalmol Soc 1997;38:1700-5.
10) Lee HK, Hu CH, Kkkang SJ, Lee SY. Clinical analysis of lid tumors. J Korean Ophthalmol Soc 1997;38:1892-8.
11) Choi JH, Chi MJ, Baek SH. Clinical analysis of benign eyelid and conjunctival tumors. J Korean Ophthalmol Soc 2003;44:1268-77.
12) Park HN, Jung SK, Cho WK, et al. Clinicopathological characteristics of malignant eyelid tumor in Korea. J Korean Ophthalmol Soc 2014;55:348-53.
13) Jang SM, Lee H, Baek SH. Clinical characteristics of benign eyelid tumors. J Korean Ophthalmol Soc 2016;57:174-80.
14) Kim H, Min JH, Choi YJ, et al. Clinical and histopathologic analysis of 148 cases of eyelid skin tumors diagnosed a tertiary hospital in Korea. Korean J Dermatol 2016;54:706-16.
15) Takamura H, Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol 2005;49:349-54.
18) Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993;38:169-92.
19) Lee JJ, Kim NJ, Choung HK, Khwarg SI. Clinical features and management of eyelid sebaceous gland carcinoma. J Korean Ophthalmol Soc 2008;49:183-9.
20) Chi MJ, Baek SH. Clinical analysis of benign eyelid and conjunctival tumors. Ophthalmologica 2006;220:43-51.
22) Mak ST, Wong AC, Io IY, Tse RK. Malignant eyelid tumors in Hong Kong 1997-2009. Jpn J Ophthalmol 2011;55:681-5.
23) Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 2005;50:103-22.
24) Lee JW, Kim SY, Jung MS. Pathological classification and incidence of conjunctival tumors in Korean patients: single-center study. J Korean Ophthalmol Soc 2019;60:119-25.
25) Shields CL, Alset AE, Boal NS, et al. Conjunctival tumors in 5,002 cases. comparative analysis of benign versus malignant counterparts. The 2016 James D. Allen lecture. Am J Ophthalmol 2017;173:106-33.
26) Knop N, Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000;41:1270-9.
28) Gupta AK, Bharadwaj M, Mehrotra R. Skin cancer concerns in people of color: risk factors and prevention. Asian Pac J Cancer Prev 2016;17:5257-64.